The new federal government last night delivered its 2022–23 ‘bread and butter’ Budget amid a growing cost-of-living crisis.

Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.

In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...

Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

A novel therapy under investigation could see pharmacists playing a greater role in helping patients to manage some common eye conditions.

Pharmacists are on the verge of a major acceleration in their scope of practice, but a shift in perspective is needed first, delegates heard...